The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis

Journal of Leukocyte Biology

Volumn 95, Issue 3, 2014, Pages 451-460

  Belkina, Anna C ^a,b   Blanton, Wanda P ^a,b   Nikolajczyk, Barbara S ^a   Denis, Gerald V ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B lymphopoiesis; BET proteins; Chromatin; Hematopoietic stem cells; Immune reconstitution; Side population

Indexed keywords

ANTINEOPLASTIC AGENT; BROMODOMAIN PROTEIN BRD2; CYCLIN A; JQ 1; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; BRD2 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; CELL COMPARTMENTALIZATION; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL EXPANSION; CONTROLLED STUDY; HEMATOPOIESIS; HISTONE ACETYLATION; IN VITRO STUDY; LARGE CELL LYMPHOMA; LENTIVIRINAE; LYMPHOPOIESIS; MALE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECIPIENT; T LYMPHOCYTE; ANIMAL; B-LYMPHOPOIESIS; BET PROTEINS; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNE RECONSTITUTION; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE POPULATION;

B-LYMPHOPOIESIS; BET PROTEINS; CHROMATIN; HEMATOPOIETIC STEM CELLS; IMMUNE RECONSTITUTION; SIDE POPULATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84899482050     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1112588     Document Type: Article

References (54)

1. Belkina, A. C., Denis, G. V. (2012) BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer 12, 465-477.
2. Haynes, S. R., Dollard, C., Winston, F., Beck, S., Trowsdale, J., Dawid, I. B. (1992) The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res. 20, 2603.
3. Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M-M. (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399, 491-496.
4. Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., Sims III, R. J. (2011) Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl. Acad. Sci. USA 108, 16669-16674.
5. Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., Taylor, M. J., Johns, C., Chicas, A., Mulloy, J. C., Kogan, S. C., Brown, P., Valent, P., Bradner, J. E., Lowe, S. W., Vakoc, C. R. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528.
6. Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., Chesi, M., Schinzel, A. C., McKeown, M. R., Heffernan, T. P., Vakoc, C. R., Bergsagel, P. L., Ghobrial, I. M., Richardson, P. G., Young, R. A., Hahn, W. C., Anderson, K. C., Kung, A. L., Bradner, J. E., Mitsiades, C. S. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917.
7. Mueller, D., Bach, C., Zeisig, D., Garcia-Cuellar, M. P., Monroe, S., Sreekumar, A., Zhou, R., Nesvizhskii, A., Chinnaiyan, A., Hess, J. L., Slany, R. K. (2007) A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110, 4445-4454.
8. Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W. I., Robson, S. C., Chung, C. W., Hopf, C., Savitski, M. M., Huthmacher, C., Gudgin, E., Lugo, D., Beinke, S., Chapman, T. D., Roberts, E. J., Soden, P. E., Auger, K. R., Mirguet, O., Doehner, K., Delwel, R., Burnett, A. K., Jeffrey, P., Drewes, G., Lee, K., Huntly, B. J., Kouzarides, T. (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529-533.
9. Greenwald, R., Tumang, J. R., Sinha, A., Currier, N., Cardiff, R. D., Rothstein, T. L., Faller, D. V., Denis, G. V. (2004) Eμ-BRD2 transgenic mice develop B cell lymphoma and leukemia. Blood 103, 1475-1484.
10. You, J., Srinivasan, V., Denis, G. V., Harrington W. J., Jr., Ballestas, M. E., Kaye, K. M., Howley, P. M. (2006) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol. 80, 8909-8919.
11. Kanno, T., Kanno, Y., Siegel, R. M., Jang, M. K., Lenardo, M. J., Ozato, K. (2004) Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell 13, 33-43.
12. Wu, S. Y., Chiang, C. M. (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 282, 13141-13145.
13. French, C. A., Ramirez, C. L., Kolmakova, J., Hickman, T. T., Cameron, M. J., Thyne, M. E., Kutok, J. L., Toretsky, J. A., Tadavarthy, A. K., Kees, U. R., Fletcher, J. A., Aster, J. C. (2007) BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27, 2237-2242.
14. Kubonishi, I., Takehara, N., Iwata, J., Sonobe, H., Ohtsuki, Y., Abe, T., Miyoshi, I. (1991) Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res. 51, 3327-3328.
15. Houzelstein, D., Bullock, S. L., Lynch, D. E., Grigorieva, E. F., Wilson, V. A., Beddington, R. S. P. (2002) Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Mol. Cell. Biol. 22, 3794-3802.
16. Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., Ozato, K. (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. USA 100, 8758-8763.
17. 2-to-M transition. Mol. Cell. Biol. 20, 6537-6549.
18. Gyuris, A., Donovan, D. J., Seymour, K. A., Lovasco, L. A., Smilowitz, N. R., Halperin, A. L., Klysik, J. E., Freiman, R. N. (2009) The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis. Biochim. Biophys. Acta 1789, 413-421.
19. Shang, E., Wang, X., Wen, D., Greenberg, D. A., Wolgemuth, D. J. (2009) Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse. Dev. Dyn. 238, 908-917.
20. Wang, F., Liu, H., Blanton, W. P., Belkina, A., LeBrasseur, N. K., Denis, G. V. (2009) Brd2 disruption in mice causes severe obesity without type 2 diabetes. Biochem. J. 425, 71-83.
21. Jang, M. K., Mochizuki, K., Zhou, M., Jeong, H. S., Brady, J. N., Ozato, K. (2005) The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19, 523-534.
22. Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., Howley, P. M. (2011) The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 31, 2641-2652.
23. Umehara, T., Nakamura, Y., Jang, M. K., Nakano, K., Tanaka, A., Ozato, K., Padmanabhan, B., Yokoyama, S. (2010) Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem. 285, 7610-7618.
24. Dey, A., Nishiyama, A., Karpova, T., McNally, J., Ozato, K. (2009) Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol. Biol. Cell 20, 4899-4909.
25. Nakamura, Y., Umehara, T., Nakano, K., Jang, M. K., Shirouzu, M., Morita, S., Uda-Tochio, H., Hamana, H., Terada, T., Adachi, N., Matsumoto, T., Tanaka, A., Horikoshi, M., Ozato, K., Padmanabhan, B., Yokoyama, S. (2007) Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4. J. Biol. Chem. 282, 4193-4201.
26. Denis, G. V., Vaziri, C., Guo, N., Faller, D. V. (2000) RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Diff. 11, 417-424.
27. Sinha, A., Faller, D. V., Denis, G. V. (2005) Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem. J. 387, 257-269.
28. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., Philpott, M., Munro, S., McKeown, M. R., Wang, Y., Christie, A. L., West, N., Cameron, M. J., Schwartz, B., Heightman, T. D., La Thangue, N., French, C. A., Wiest, O., Kung, A. L., Knapp, S., Bradner, J. E. (2010) Selective inhibition of BET bromodomains. Nature 468, 1067-1073.
29. Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C. W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., White, J., Kirilovsky, J., Rice, C. M., Lora, J. M., Prinjha, R. K., Lee, K., Tarakhovsky, A. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119-1123.
30. Denis, G. V., Green, M. R. (1996) A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulator. Genes Dev. 10, 261-271.
31. Beck, S., Hanson, I., Kelly, A., Pappin, D. J., Trowsdale, J. (1992) A homologue of the Drosophila female sterile homeotic (fsh) gene in the class II region of the human MHC. DNA Seq. 2, 203-210.
32. Dunphy, E. L., Johnson, T., Auerbach, S. S., Wang, E. H. (2000) Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression. Mol. Cell. Biol. 20, 1134-1139.
33. Mochizuki, K., Nishiyama, A., Jang, M. K., Dey, A., Ghosh, A., Tamura, T., Natsume, H., Yao, H., Ozato, K. (2008) The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. J. Biol. Chem. 283, 9040-9048.
34. Denis, G. V., McComb, M. E., Faller, D. V., Sinha, A., Romesser, P. B., Costello, C. E. (2006) Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J. Proteome Res. 5, 502-511.
35. Garcia-Gutierrez, P., Mundi, M., Garcia-Dominguez, M. (2012) Association of bromodomain BET proteins to the chromatin requires dimerization through the conserved motif B. J. Cell Sci. 125, 3671-3680.
36. Lenburg, M., Sinha, A., Faller, D. V., Denis, G. V. (2007) Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J. Biol. Chem. 282, 4803-4811.
37. Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., Mulligan, R. C. (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806.
38. Amendola, M., Venneri, M. A., Biffi, A., Vigna, E., Naldini, L. (2005) Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat. Biotechnol. 23, 108-116.
39. 1-antitrypsin after transplantation of manipulated hematopoietic stem cells. Am. J. Respir. Cell. Mol. Biol. 39, 133-141.
40. Weksberg, D. C., Chambers, S. M., Boles, N. C., Goodell, M. A. (2008) CD150-side population cells represent a functionally distinct population of long-term hematopoietic stem cells. Blood 111, 2444-2451.
41. Challen, G. A., Boles, N. C., Chambers, S. M., Goodell, M. A. (2010) Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1. Cell Stem Cell 6, 265-278.
42. Camargo, F. D., Chambers, S. M., Drew, E., McNagny, K. M., Goodell, M. A. (2006) Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 107, 501-507.
43. Digan, M. E., Haynes, S. R., Mozer, B. A., Dawid, I. B., Forquignon, F., Gans, M. (1986) Genetic and molecular analysis of fs(1)h, a maternal effect homeotic gene in Drosophila. Dev. Biol. 114, 161-169.
44. Chua, P., Roeder, G. S. (1995) Bdf1, a yeast chromosomal protein required for sporulation. Mol. Cell. Biol. 15, 3685-3696.
45. Romesser, P. B., Perlman, D. H., Faller, D. V., Costello, C. E., McComb, M. E., Denis, G. V. (2009) Development of a malignancy-associated proteomic signature for diffuse large B cell lymphoma. Am. J. Pathol. 175, 25-35.
46. Belkina, A. C., Nikolajczyk, B. S., Denis, G. V. (2013) BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J. Immunol. 190, 3670-3678.
47. LeRoy, G., Rickards, B., Flint, S. J. (2008) The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell 30, 51-60.
48. Kalaszczynska, I., Geng, Y., Iino, T., Mizuno, S., Choi, Y., Kondratiuk, I., Silver, D. P., Wolgemuth, D. J., Akashi, K., Sicinski, P. (2009) Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 138, 352-365.
49. Kamminga, L. M., Bystrykh, L. V., de Boer, A., Houwer, S., Douma, J., Weersing, E., Dontje, B., de Haan, G. (2006) The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 107, 2170-2179.
50. Mozer, B. A., Dawid, I. B. (1989) Cloning and molecular characterization of the trithorax locus of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 86, 3738-3742.
51. Mazo, A. M., Huang, D. H., Mozer, B. A., Dawid, I. B. (1990) The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proc. Natl. Acad. Sci. USA 87, 2112-2116.
52. Cimino, G., Moir, D. T., Canaani, O., Williams, K., Crist, W. M., Katzav, S., Cannizzaro., L., Lange, B., Nowell, P. C., Croce, C. M., Canaani, E. (1991) Cloning of ALL-1, the locus involved in leukemias with the t(4; 11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 51, 6712-6714.
53. Moore, M. A. (2005) Converging pathways in leukemogenesis and stem cell self-renewal. Exp. Hematol. 33, 719-737.
54. Ott, C. J., Kopp, N., Bird, L., Paranal, R. M., Qi, J., Bowman, T., Rodig, S. J., Kung, A. L., Bradner, J. E., Weinstock, D. M. (2012) BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood 120, 2843-2852.